West Announces Second-Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
West Pharma (WST) Tops Q2 EPS by 72c; Raises Outlook
July 29, 2021 6:44 AM EDTWest Pharma (NYSE: WST) reported Q2 EPS of $2.46, $0.72 better than the analyst estimate of $1.74. Revenue for the quarter came in at $723.6 million versus the consensus estimate of $669.38 million.
GUIDANCE:
West Pharma sees FY2021 EPS of $8.05-$8.20, versus the consensus of... More
